Literature DB >> 1510686

Evidence for thiophene-S-oxide as a primary reactive metabolite of thiophene in vivo: formation of a dihydrothiophene sulfoxide mercapturic acid.

P M Dansette1, D C Thang, H el Amri, D Mansuy.   

Abstract

Urine of rats treated with thiophene contains a very major metabolite which represents about 30% of the administered dose. A detailed analysis of its 1H and 13C NMR spectra and a study of its IR and mass spectra clearly showed that it was a 2,5-dihydrothiophene sulfoxide bearing a N-acetyl-cysteinyl group on position 2. Upon heating, it lost water with formation of N-acetyl-S-(2-thienyl)-L-cysteine. A likely mechanism for the formation of this metabolite should involve the S-oxidation of thiophene as a primary step and the addition of glutathione to the very reactive thiophene-S-oxide. These data provide a first evidence for the intermediate formation in vivo of thiophene-S-oxides as reactive metabolites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510686     DOI: 10.1016/s0006-291x(05)81594-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Cytochromes P450 and drug toxicity. Immunological consequences.

Authors:  D Mansuy
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 2.  Drug-induced immunotoxicity.

Authors:  P M Dansette; E Bonierbale; C Minoletti; P H Beaune; D Pessayre; D Mansuy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Oct-Dec       Impact factor: 2.441

3.  Abundant Rodent Furan-Derived Urinary Metabolites Are Associated with Tobacco Smoke Exposure in Humans.

Authors:  Alex E Grill; Thaddeus Schmitt; Leah A Gates; Ding Lu; Dipankar Bandyopadhyay; Jian-Min Yuan; Sharon E Murphy; Lisa A Peterson
Journal:  Chem Res Toxicol       Date:  2015-07-07       Impact factor: 3.739

4.  Computational Approach to Structural Alerts: Furans, Phenols, Nitroaromatics, and Thiophenes.

Authors:  Na Le Dang; Tyler B Hughes; Grover P Miller; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2017-03-14       Impact factor: 3.739

5.  Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug.

Authors:  Hsia-lien Lin; Haoming Zhang; Christine Medower; Paul F Hollenberg; William W Johnson
Journal:  Drug Metab Dispos       Date:  2010-11-10       Impact factor: 3.922

6.  Differential oxidation of two thiophene-containing regioisomers to reactive metabolites by cytochrome P450 2C9.

Authors:  Peter M Rademacher; Caleb M Woods; Qingbiao Huang; Grazyna D Szklarz; Sidney D Nelson
Journal:  Chem Res Toxicol       Date:  2012-03-14       Impact factor: 3.739

7.  Conformational turn triggers regio-selectivity in the bioactivation of thiophene-contained compounds mediated by cytochrome P450.

Authors:  Chun-Zhi Ai; Yong Liu; Du-Chu Chen; Yasmeen Saeed; Yi-Zhou Jiang
Journal:  J Biol Inorg Chem       Date:  2019-09-10       Impact factor: 3.358

8.  Modeling Small-Molecule Reactivity Identifies Promiscuous Bioactive Compounds.

Authors:  Matthew K Matlock; Tyler B Hughes; Jayme L Dahlin; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2018-07-23       Impact factor: 6.162

Review 9.  Monooxygenase- and Dioxygenase-Catalyzed Oxidative Dearomatization of Thiophenes by Sulfoxidation, cis-Dihydroxylation and Epoxidation.

Authors:  Derek R Boyd; Narain D Sharma; Paul J Stevenson; Patrick Hoering; Christopher C R Allen; Patrick M Dansette
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.